Molybdopterin is the essential, invariant component of the cofactors of all mononuclear molybdenum and tungsten-containing enzymes. Most prokaryotic enzymes contain dinucleotide forms of molybdopterin complexed with GMP, AMP, CMP or IMP. The most elaborate form of the cofactor is bis(molybdopterin guanine dinucleotide)-Mo, first identified in R. sphaeroides dimethyl sulfoxide reductase (DMSOR) which contains no other cofactor. R. sphaeroides biotin sulfoxide reductase (BSOR) and E. coli trimethylamine-N-oxide reductase (TMAOR) also contain bis(molybdopterin guanine dinucleotide)-Mo as their sole cofactor, and all three enzymes have been cloned and successfully expressed in E. coli. In collaboration with crystallographers at other universities, the X-ray crystal structure of DMSOR has been determined. BSOR is of particular interest since it is the only enzyme among the three that uses NADPH as an electron donor. Detailed steady state and stopped-flow kinetic analysis will be used to compare the mechanism of action of both wild type and site-directed mutagenesis-derived variants of DMSOR, BSOR TMAOR with their native electron donors. Giant strides have been made in our studies of the biosynthesis of the molybdenum cofactor in E. coli, both at the mechanistic and structural level. All of the biosynthetic proteins have been expressed and purified, and in vitro assay systems have been developed for the formation of the dithiolene moiety of the cofactor, incorporation of molybdenum, and formation of the guanine dinucleotide form of the cofactor. In collaboration with Dr. Hermann Schindelin at SUNY Stow Brook, the crystal structures of all of the cofactor biosynthesis proteins have been determined with the exception of MoaA, the first protein in the pathway. Along with the in vitro assays, these structures generate an unlimited vista for future structure-function studies of each step in the pathway using variants generated by site-directed mutagenesis. Optimization of MoaA expression and purification will be undertaken to generate sufficient quantities of soluble protein for structural determination and for studies of the formation of precursor Z, the first intermediate in the pathway. A complete understanding of cofactor biosynthesis is of great importance since molybdenum cofactor deficiency in humans causes severe neurological defects and generally results in infant fatality.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM000091-60
Application #
6902660
Study Section
Physical Biochemistry Study Section (PB)
Program Officer
Jones, Warren
Project Start
1977-06-01
Project End
2008-05-31
Budget Start
2005-06-01
Budget End
2006-05-31
Support Year
60
Fiscal Year
2005
Total Cost
$567,610
Indirect Cost
Name
Duke University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Leimkühler, Silke; Wuebbens, Margot M; Rajagopalan, K V (2011) The History of the Discovery of the Molybdenum Cofactor and Novel Aspects of its Biosynthesis in Bacteria. Coord Chem Rev 255:1129-1144
George, Graham N; Nelson, Kimberly Johnson; Harris, Hugh H et al. (2007) Interaction of product analogues with the active site of rhodobacter sphaeroides dimethyl sulfoxide reductase. Inorg Chem 46:3097-104
Nichols, Jason D; Xiang, Song; Schindelin, Hermann et al. (2007) Mutational analysis of Escherichia coli MoeA: two functional activities map to the active site cleft. Biochemistry 46:78-86